BioSpace News Archive

Drug Development

Bionomics Initiates Phase 2 PREVAIL Study of BNC210 for the Acute Treatment of Social Anxiety Disorder

Bionomics Limited, a clinical-stage biopharmaceutical company, is pleased to announce that it has initiated its Phase 2 clinical trial to evaluate BNC210 for the acute treatment of Social Anxiety Disorder, with topline results expected by the end of 2022.

January 3, 2022
·
5 min read
BioMidwest

Exact Sciences to participate in J.P. Morgan Healthcare Conference - Jan 03, 2022

Exact Sciences Corp. announced that company management will participate in the following virtual conference and invited investors to participate by webcast.

January 3, 2022
·
1 min read
Biotech Bay

IDEAYA Biosciences to Participate in Investor Conferences in January 2022

IDEAYA Biosciences, Inc., a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in investor conferences in January 2022.

January 3, 2022
·
2 min read
Business

Immuneering Appoints Rimma Steinhertz, Ph.D., PMP as Vice President, Project and Alliance Management

Immuneering Corporation today announced the appointment of Rimma Steinhertz, Ph.D., PMP to the newly created position of Vice President, Project and Alliance Management, effective immediately.

January 3, 2022
·
4 min read
Pharm Country

Passage Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference

Passage Bio, Inc. today announced that Bruce Goldsmith, Ph.D., president, and chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference being held virtually on Monday, January 10, 2022 at 10:30 a.m. ET.

January 3, 2022
·
1 min read
Genetown

Cerevel to Present at the 40th Annual J.P. Morgan Healthcare Conference

Cerevel Therapeutics today announced that Chairperson and Chief Executive Officer Tony Coles, M.D., will present at the upcoming virtual 40th Annual J.P. Morgan Healthcare Conference.

January 3, 2022
·
4 min read
Genetown

Curis to Present at H.C. Wainwright BioConnect Conference

Curis, Inc. today announced that James Dentzer, President and Chief Executive Officer of Curis, will present at the H.C. Wainwright BioConnect Conference.

January 3, 2022
·
1 min read
Drug Development

Pieris Pharmaceuticals Announces Successful Completion of Safety Milestone and Initiation of Efficacy Portion of Phase 2a Trial of PRS-060/AZD1402

Pieris Pharmaceuticals, Inc. today announced the successful completion of the sponsor safety review of part 1a of the multi-center, placebo-controlled phase 2a study of dry powder inhaler-formulated PRS-060/AZD1402.

January 3, 2022
·
6 min read
Genetown

Relay Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 9:45 a.m. ET.

January 3, 2022
·
1 min read
Business

9 Meters Biopharma Appoints Sarah Liu as Chief Commercial Officer and Al Medwar as Senior Vice President of Investor Relations & Corporate Communications

9 Meters Biopharma, Inc. announced today the Company has appointed Sarah Liu, MBA, as Chief Commercial Officer and Al Medwar, MBA, as Senior Vice President, Investor Relations & Corporate Communications.

January 3, 2022
·
6 min read